Sign in
EOLS Stock Price, Chart, Stats & News
Evolus, Inc.
Save
440.00M
Market cap
–
Current P/E
60.24x
Forward P/E
EOLS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 64.86% |
Operating margin | -12.51% |
Pretax margin | -17.15% |
Net margin | -17.38% |
Effective tax rate | -1.33% |
ROA | -22.86% |
ROE | 267.84% |
D/E | -6.71x |
Interest coverage ratio | -1.89x |
EOLS valuation
P/E | – |
P/S | 0.88x |
P/B | -11.19x |
P/CF | -6.12x |
P/FCF | -5.38x |
P/OCF | -6.12x |
PEG | -0.42x |
EV multiple | -5.78x |
About
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines.
Similar securities
Based on sector and market capitalization
Report issue